Human Molecular GeneticsGeneticsPeer-reviewed journal article
MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells
Silvie FranckiD, Lise BarbéiD, Simon Ardui, Yannick De VlaeminckiD, Joke Allemeersch, Dominika DziedzickaiD, Claudia SpitsiD, Fien VanroyeiD, Pierre Hilven, Geoffrey Duqué, Joris Robert VermeeschiD, Alexander GheldofiD, Karen SermoniD
Abstract
Myotonic dystrophy type 1 (DM1) is caused by expansion of a CTG repeat in the DMPK gene, where expansion size and somatic mosaicism correlates with disease severity and age of onset. While it is known that the mismatch repair protein MSH2 contributes to the unstable nature of the repeat, its role on other disease-related features, such as CpG methylation upstream of the repeat, is unknown. In this study, we investigated the effect of an MSH2 knock-down (MSH2KD) on both CTG repeat dynamics and CpG methylation pattern in human embryonic stem cells (hESC) carrying the DM1 mutation. Repeat size in MSH2 wild type (MSH2WT) and MSH2KD DM1 hESC was determined by PacBio sequencing and CpG methylation by bisulfite massive parallel sequencing. We found stabilization of the CTG repeat concurrent with a gradual loss of methylation upstream of the repeat in MSH2KD cells, while the repeat continued to expand and upstream methylation remained unchanged in MSH2WT control lines. Repeat instability was re-established and biased towards expansions upon MSH2 transgenic re-expression in MSH2KD lines while upstream methylation was not consistently re-established. We hypothesize that the hypermethylation at the mutant DM1 locus is promoted by the MMR machinery and sustained by a constant DNA repair response, establishing a potential mechanistic link between CTG repeat instability and upstream CpG methylation. Our work represents a first step towards understanding how epigenetic alterations and repair pathways connect and contribute to the DM1 pathology.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- approach: statistical model
- Citations
- 11
- FWCI
- 0.57
- Field percentile
- top 41%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deletion of the CTG Expansion in Myotonic Dystrophy Type 1 Reverses DMPK Aberrant Methylation in Human Embryonic Stem Cells but not Affected Myoblasts
Shira Yanovsky‐Dagan, Ester Bnaya, … Rachel Eiges·bioRxiv·May 8, 2019
- CCG interruptions are unstable and hypermethylated in DM1 patients
Sonia Lameiras, Eirini-Maria Lampraki, … Stéphanie Tomé·bioRxiv·Oct 10, 2024
- MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome
Jessalyn Grant-Bier, Kathryn Ruppert, … Daman Kumari·bioRxiv·Dec 20, 2024
- Base-resolution DNA methylome of human MDS hematopoietic stem cell reveals TET2-GFI1 epigenetic axis repressing MDS
Liangding Hu, Qicong Shen, … Xuetao Cao·Immunity & InflammationPeer-reviewed·Apr 1, 2026
- Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1
Qi Yin, Hongye Wang, … Jinsong Li·Cell ResearchPeer-reviewed·Dec 18, 2019
- DNMT1 overexpression disrupts DNA methylation homeostasis in mouse embryonic stem cells
Elizabeth Elder, Anthony Lemieux, Serge McGraw·bioRxiv·Jun 24, 2026